Jun 14, 2023, 18:35
Can we improve the delivery of eribulin by linking it to a HER2 mAb?
In a post by Paolo Tarantino on Twitter, it says, “Can we improve the delivery of eribulin by linking it to a HER2 mAb? In a cohort of 29 patients with HER2-expressing tumors (65% breast), BB-1701 achieved an ORR of 50% (70% for breast), with durable responses. High rates of peripheral neuropathy (69%).”
Source: Paolo Tarantino/Twitter